Telomir Pharmaceuticals, Inc. Common StockTELONASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending lower, below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-5.07M
↓ 113% below average
Average (3y)
$-2.38M
Historical baseline
Range
High:$-119400.00
Low:$-5.07M
CAGR
+248.9%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-5.07M | -31.4% |
| 2023 | $-3.86M | -723.6% |
| 2022 | $-468661.00 | -292.5% |
| 2021 | $-119400.00 | - |